Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
NitWitt's Profile
Displaying 1-8 of 8 result(s).
NTEK Nanotech Entertainment Inc.
05/18/2014 10:26:24 AM
Shareholders meeting highlights 60,
NTEK Nanotech Entertainment Inc.
02/18/2014 2:40:56 PM
Amazing I bought 5,000 shares on th
NTEK Nanotech Entertainment Inc.
02/18/2014 1:46:25 PM
Amazing 5,000 ask/bid spread is con
NTEK Nanotech Entertainment Inc.
02/14/2014 3:26:15 PM
Best quarter we have seen! Can't wa
NTEK Nanotech Entertainment Inc.
02/07/2014 4:30:25 PM
I am not going to bash this stock I
NTEK Nanotech Entertainment Inc.
02/07/2014 3:52:14 PM
LOL! I would love to do that but I
NTEK Nanotech Entertainment Inc.
02/07/2014 1:01:17 PM
This isn't Nitt Witt from ihub lol!
NTEK Nanotech Entertainment Inc.
02/07/2014 12:43:19 PM
Ask is getting hit hard but the mom

Recent Articles

  • Protect Your Investment: Join the Dow Inc. Class Action Today
  • CTO Realty Growth, Inc. Class Action Deadline Approaches Soon
  • Sam Altman's Perspective on AI and Farming as a Backup Plan
  • Star Princess Embarks on Its Inaugural Voyage from Spain
  • Unicoin, Inc. Investors: Explore Securities Class Action Options
  • How Taylor Swift’s Strategy Can Inspire Your Success Journey
  • Barbara Corcoran's Key Traits for Entrepreneurial Success
  • Investors Urged to Participate in Cytokinetics Action for Rights
  • Urgent Action for PubMatic Investors: Class Action Details
  • Public Opinions Shift on Economic Policies Amid Turmoil
  • Lawsuit Against Tesla Highlights Concerns Over Cybertruck Safety
  • Cytokinetics Investors Urged to Seek Legal Counsel Soon
  • Innovative AI Agent Infrastructure Secures Funding for Growth
  • BOE O•SPACE Celebrates Eastern Aesthetics in Milan Exhibition
  • Important Class Action Alert for Fortinet, Inc. Investors
  • Class Action Lawsuit Aims to Hold KinderCare Accountable
  • Bitcoin Approaches Historic High as Investors Seek Stability
  • Kiyosaki Questions Buffett's Shift to Gold and Silver Investments
  • Yutong's Innovative EV Technology Makes Waves at Busworld Europe
  • Bragar Eagel & Squire Encourages Investors to Act Now
  • Lantheus Holdings Faces Class Action: Key Information for Investors
  • Investors Alert: Class Action Rights for VFC, CYTK, NX, and RICK
  • Exploring Exclusive Industries That Cater to the Wealthy Elite
  • MG COMMERCIAL Unveils All-Electric Bus Line at Major Event
  • BOE O•SPACE Brings Eastern Aesthetics to Milan's ICH Exhibition
  • Kevin Hart's Bold Encounter with Jeff Bezos at a Party
  • Fortinet Investors: Class Action Lawsuit and Your Rights
  • Revisiting Jasper Therapeutics: What Investors Need to Know
  • Securing Your Rights: Join the Snap Inc. Class Action Today
  • Macao Showcases Culture at World Expo 2025 in Osaka
  • Senate Vote Fails Again, Extending Government Shutdown Further
  • The Transformative Impact of Musk's Starlink on Telecom Industry
  • The Coming of a Global Basketball League and Its Visionary Impact
  • Growth of HPV Testing and Pap Smear Market Leading to Innovation
  • Forecasting the Explosive Growth of Streaming Analytics by 2030
  • Financial Gravity Companies Secures Major Credit Facility Boost
  • This Week's Top Stocks: Trends, Insights, and Performance Report
  • Access Control Market Poised for $15.80 Billion Surge by 2030
  • Understanding the Impact of Farming on Food Prices and Emissions
  • Discovering Overlooked Stocks: Insights into Top Firms
  • TECO Partners with BRIST to Launch Innovative EV Solutions
  • Direxion to Liquidate Three ETFs: What Investors Should Know
  • Elevate Your Business Travel with the New FLO 5 Core Suitcase
  • Exploring Insights and Trends from Recent Studies
  • Kroger Recalls Deli Pasta Salads Over Health Safety Concerns
  • Market Highlights: Bullish Trends in Technology Stocks
  • Project AnimalAid's Commitment to Compassion and Sustainability
  • Explore the Innovative UWANT D100 Vacuum Cleaner This Prime Day
  • CarMax Faces Serious Securities Fraud Investigation Risks
  • MoonLake Immunotherapeutics Under Scrutiny for Drug Trials Issues
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site